Press Releases

September 14, 2020
SAN JOSE, Calif.--( BUSINESS WIRE )--Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced the pricing of its upsized initial public offering of 8,951,111 shares of its common stock at a public offering price of $27.00 per share, for total gross proceeds of approximately $241.7 million,
June 3, 2020
3 June 2020 Outset Medical Appoints New General Counsel Outset Medical, a leading med tech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced the appointment of John Brottem as the company’s new General Counsel.
April 1, 2020
First new device cleared for home hemodialysis in 15 years   SAN JOSE, Calif.–(BUSINESS WIRE)– Outset Medical, a leading med tech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced the Food and Drug Administration (FDA) cleared the Tablo
February 4, 2020
Financing to Support Commercial Acceleration of the Tablo® Hemodialysis System, an Enterprise Solution Designed to Reduce the Cost and Complexity of Dialysis SAN JOSE, Calif., — Outset Medical, a leading medtech innovator delivering first-of-its-kind technology into the growing global dialysis